Nan Yao

1.7k citations
31 papers · 1.3k indexed · 1 hit paper · h-index 18
Topics
MicroRNA in disease regulation (4 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers)Cancer Mechanisms and Therapy (4 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEHepatology

In The Last Decade

Nan Yao

31 papers receiving 1.3k citations

Hit Papers

Autophagy and multidrug resistance in cancer20172026202020232017100200300400500

Peers

Nan Yao
Comparison fields: 5 of 94
  • Molecular Biology 854
  • Epidemiology 331
  • Cancer Research 306
  • Oncology 266
  • Immunology 129
Replace Yuhe Lei with:
Yuhe Lei China
Arumugam Nagalingam United States
Yurai Okaji Japan
Sonia Emanuele Italy
Shuo Deng Singapore
Zebo Jiang China
Alok Ranjan United States
Mano Horinaka Japan
Miki Wakada Japan
Daniela Carlisi Italy
Nan Yao relative to Yuhe Lei China Yuhe Lei's profile →
Citations per field
00.5×10×17×
Yuhe Lei · 1×
Citations per year

Countries citing papers authored by Nan Yao

Since Specialization
Citations

This map shows the geographic impact of Nan Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Yao more than expected).

Fields of papers citing papers by Nan Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Yao. The network helps show where Nan Yao may publish in the future.

Co-authorship network of co-authors of Nan Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Nan Yao. A scholar is included among the top collaborators of Nan Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Yao. Nan Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 8
3 2
4 1
5 10
6 8
7 20
8 32
9 27
10 46
11 17
12
Autophagy and multidrug resistance in cancerbreakdown →
559
13 59
14 24
15 21
16 27
17 87
18 38
19 18
20 20

About Nan Yao

Nan Yao is a scholar working on Oncology, Cancer Research and Toxicology, having authored 31 papers that have together received 1.3k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Cancer Mechanisms and Therapy (4 papers). The work is most often cited by research in Cancer Research (306 citations), Toxicology (43 citations) and Molecular Biology (854 citations). Nan Yao has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Dongmei Zhang, Wen‐Cai Ye, Zhe‐Sheng Chen, Yingjie Li, Chenran Wang, Nan Hu, Yuhe Lei, Minfeng Chen, Lijuan Deng and Jianyang Hu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026